JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4,096 Cr | ₹4,006 Cr | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr |
What is the latest Total Non-Current Liabilities ratio of JUBILANT PHARMOVA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹4,096 Cr |
Mar2024 | ₹4,006 Cr |
Mar2023 | ₹3,765 Cr |
Mar2022 | ₹2,922 Cr |
Mar2021 | ₹2,973 Cr |
How is Total Non-Current Liabilities of JUBILANT PHARMOVA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4,096 Cr | 2.25 | |
Mar2024 | ₹4,006 Cr | 6.39 | |
Mar2023 | ₹3,765 Cr | 28.87 | |
Mar2022 | ₹2,922 Cr | -1.73 | |
Mar2021 | ₹2,973 Cr | - |
Compare Total Non-Current Liabilities of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹17,229.9 Cr | 0.4% | -11.6% | 18.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 0.4% |
-11.6% |
18.9% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses